Biotech

All Articles

8 months after a $213M fundraise, gene editor Volume creates cuts

.After bring up $213 thousand in 2023-- among the year's biggest personal biotech rounds-- Tome Bios...

BioMarin builds director crew with biotech vets-- Chutes &amp Ladders

.Accept to today's Chutes &amp Ladders, our roundup of notable leadership hirings, firings and retir...

Biopharma Q2 VC attacked highest level since '22, while M&ampA reduced

.Venture capital backing in to biopharma rose to $9.2 billion around 215 deals in the second quarter...

Bicara, Zenas look for IPOs to push late-phase assets toward market

.Bicara Therapeutics and also Zenas Biopharma have delivered new incentive to the IPO market with fi...

Genentech to close cancer cells immunology research team

.Genentech will close its cancer cells immunology research study team, and unit mind and also renown...

Kezar goes down sound tumor however to show its own really worth in phase 1 test

.Kezar Lifestyle Sciences is losing its own dim period 1 strong growth drug as the biotech goes all-...

Acelyrin loses izokibep, dismisses 3rd of personnel

.Despite izokibep preserving its newfound winning streak in the medical clinic, Acelyrin is actually...

Rivus' stage 2 obesity-related heart failure trial hits endpoint

.Rivus Pharmaceuticals has plumped up the leads of its own fat-busting, muscle-sparing medication ap...

Ovid halts preclinical job, IV program after soticlestat fail

.Ovid Rehab currently uncovered last month that it was trimming back its own headcount as the compan...

Eli Lilly opens up $700M nucleic acid R&ampD center in Boston Seaport

.Eli Lilly has actually opened a $700 thousand R&ampD center in the Boston ma Port, boosting its own...